Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant human thymosin alpha 1 for chronic hepatitis B
CTR20150489Phase 3Completed
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Start
- Sep 2015
- Modality
- Modified Peptides → Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of thymosin alpha 1 in Chronic Hepatitis B (CHB), sponsored by Changchun GeneScience Pharmaceutical Co., Ltd.. Started Sep 2015; status: completed.
02
Drugs
thymosin alpha 1
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on CTR20150489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150489.